Mainz Biomed B.V. (MYNZ) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Mainz Biomed B.V.

    NASDAQ: MYNZ · Real-Time Price · USD
    1.73
    0.09 (5.49%)
    At close: Oct 03, 2025, 3:59 PM
    1.67
    -3.76%
    After-hours: Oct 03, 2025, 07:46 PM EDT

    Mainz Biomed B.V. Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 373.22K 520.77K 214.76K 500.21K 251.4K 278.48K 160.04K 417.31K
    Cost of Revenue
    		 117.37K 201.74K 163.49K 222.33K 217.99K 129.74K 334.95K 64.77K
    Gross Profit
    		 255.84K 319.04K 40.25K 277.88K 33.41K 148.74K -174.92K 352.54K
    Operating Income
    		 -8.89M -9.81M -12.23M -12.98M -12.28M -13.9M -9.47M -240.75K
    Interest Income
    		 n/a n/a n/a n/a 57.5K 231.83K 170.12K 169.05K
    Pretax Income
    		 -10.63M -11.02M -5.18M -13.12M -12.51M -13.88M -11.43M -240.75K
    Net Income
    		 -10.63M -11.02M -5.18M -13.27M -12.58M -13.88M -11.43M -240.75K
    Selling & General & Admin
    		 5.89M 6.88M 8.6M 7.94M 9.47M 13.34M 9.03M 240.75K
    Research & Development
    		 2.6M 3.24M 3.85M 5.25M 2.96M 696.29K 260.54K 206.15K
    Other Expenses
    		 656.34K n/a 1.45M 62.74K n/a n/a 10.75K 10.75K
    Operating Expenses
    		 9.14M 10.13M 13.9M 13.25M 12.45M 13.91M 11.08M 240.75K
    Interest Expense
    		 1.08M n/a 662.86K 146.72K 289.32K n/a 84.79K 84.79K
    Selling & Marketing Expenses
    		 2.33M 2.36M 1.25M 3.12M 2.1M 2.88M 807.19K 150.34K
    Cost & Expenses
    		 9.26M 10.33M 14.06M 13.48M 12.67M 14.04M 11.42M 240.75K
    Income Tax Expense
    		 n/a n/a n/a 146.72K -213.14K n/a 84.79K n/a
    Shares Outstanding (Basic)
    		 968.23K 558.75K 442.04K 29.38M 14.16M 13.82M 8.81M 12.01M
    Shares Outstanding (Diluted)
    		 968.23K 558.75K 442.04K 29.38M 14.16M 14.29M 8.81M 12.01M
    EPS (Basic)
    		 -7.71 -19.73 -11.73 -0.9 -0.87 -1 -1.3 -0.02
    EPS (Diluted)
    		 -7.71 -19.73 -11.73 -0.9 -0.89 -0.98 -1.3 -0.02
    EBITDA
    		 -10.09M -9.47M -12.61M -12.4M -11.88M -13.84M -9.5M -219.8K
    EBIT
    		 -10.77M -9.81M -13.07M -12.98M -12.2M -13.9M -9.47M -254.63K
    Depreciation & Amortization
    		 680.89K 336.15K 459.82K 574.7K 404.4K 55.02K -28.26K 34.84K

    Add to Watchlist